Skip to main content
. Author manuscript; available in PMC: 2010 Feb 15.
Published in final edited form as: Cancer Res. 2009 Feb 3;69(4):1429–1438. doi: 10.1158/0008-5472.CAN-08-2343

Table 1.

Baseline characteristics of prostate cancer cases and controls

Cases (n=982) Controls (n=851) p-value*
Age at randomization, years 58.5 (5.2) 58.0 (5.0) 0.06
Cigarettes / day 19.3 (8.5) 19.1 (8.4) 0.67
Years smoked 36.3 (9.0) 36.7 (8.4) 0.57
Body mass index, kg/m2 26.2 (3.5) 26.2 (3.7) 0.81
Height, cm 174 (6) 174 (6) 0.82
Serum α-tocopherol, mg/L 11.9 (3.1) 12.0 (3.2) 0.68
Serum cholesterol, mmol/L 6.27 (1.12) 6.27 (1.18) 0.73
Daily dietary intake
    Energy, kcal 2663 (726) 2646 (735) 0.64
    Red meat, g 68.8 (31.5) 69.8 (33.2) 0.92
    α-Tocopherol, mg 10.3 (4.9) 10.2 (4.7) 0.72
    Lycopene, μg 804 (673) 799 (687) 0.52
α-Tocopherol intervention, n (%) yes 450 (45.8) 391 (46.0) 0.96
Education > primary school, n (%) 372 (37.9) 302 (35.5) 0.29
Family history of prostate cancer, n (%) yes 56 (6.51) 24 (3.18) 0.002
History of prostatic enlargement, n (%) yes 50 (5.09) 35 (4.11) 0.32
History of diabetes, n (%) yes 31 (3.16) 20 (2.35) 0.30
*

From Wilcoxon rank sum tests for continuous variables and χ2 test for categorical variables

Based on 939 cases and 816 controls

Based on 860 cases and 755 controls